Caregiver, patient, Cofounder @Carestry_ working to improve family caregiving through tech, personalization and automation @MITSloan @NorthwesternU alum
In just five short months, #TBCPartner Rapport Tx has moved from stealth to a $150M Series B round, supporting its mission to tackle one of neuromedicine’s biggest challenges: to target specific parts of the brain for a more precise approach to treatment. https://t.co/W5ksGUJjWO
Congrats to new #TBCPartner@CerapedicsInc on announcing the expansion of its Denver area headquarters! The expansion will support the growth of its products, including FDA-approved i-FACTOR® bone graft, and its mission to repair bones & heal lives. https://t.co/xSMwqFZUny
#TBCPartner Tenpoint Therapeutics has a revolution in sight! Congrats to the team on launching today with a $70M Series A to transform the treatment of ocular diseases through vision-restoring engineered cell-based therapeutics and in vivo reprogramming: https://t.co/JByk0wZ1y5
We partnered with @C4Therapeutics to elevate their online presence & showcase their transformative work in targeted protein degradation (TPD). Check out the newly launched site, a hub of visually compelling content that explains the potential impact of TPD https://t.co/qB71z1KJMI
Congratulations to TBC partner @Sarepta on the approval of the first gene therapy for Duchenne muscular dystrophy. It is a pivotal moment for the DMD community in urgent need of new therapies. We’re proud to support this monumental advance for patients.
The Health Equity Report Card (HERC) contains 17 measurable actions to reduce disparities and #CloseTheCareGap for people with cancer. More information is coming on #WorldCancerDay, February 4: https://t.co/F5T4lf8DsC. (Image 15 of 17)
@NMQF@ACSCAN
The 5-yr survival rate for #pancreaticcancer increased to 12% according to @AmericanCancer@NCICancerStats! For the first time since 2017, it's increased 2 years in a row. This promising trend points to continued progress in the fight against this disease. Let's keep going. 💜💪
Join us in welcoming @JoshMadej as he joins TBC as VP, digital and social engagement. Josh brings a passion for caregivers and patients, and over 15 years of experience in digital and social strategy, execution and analytics across the healthcare space.
January is Pancreatic Cancer Clinical Trials Awareness Month! 🔬🧪 All month long, we'll be sharing resources, information and patient stories to help you learn more about this important treatment option.
Listen in as this pancreatic cancer power couple shares how they're fighting as a family while providing some great advice on the power of acceptance and how to support a cancer survivor as a friend and family member.
https://t.co/dZ0URwYzjT
#beatpancreaticcancer
Today, @ASCO & ACCC released resources to help research sites increase equity, diversity & inclusion in cancer #clinicaltrials & address barriers to participation.
- Just ASK™ Training Program & Guide
- Site Self-Assessment
Access both for free: https://t.co/lZNViNJPF0 #ASCOACCC
Dr. Susan Tsai discusses her research into the causes of pancreatic cancer surgery and treatment disparities for underserved communities. Click here to read: https://t.co/jw7HG90rFC
🎙 On this week's Project Purple Podcast we hear from Dr. Michael Pishvaian of Johns Hopkins, who shares his unique perspective on the treatment of pancreatic cancer and life-saving research. Check out the episode:
https://t.co/i9uWohVDGG
Hey @LinkedIn, thanks for this!
Hey family #caregivers, heads-up that you can now add 'career break' *and* specify #caregiving on your LinkedIn profile.
Sweet!
https://t.co/bMk1YsC52n
.@LolaRahib and Patrick van der Valk explain how @CancerCommons and @xCures are using real-world data to improve care for future patients. https://t.co/HYcjGwOX60